This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An exploratory phase IIa study to evaluate the saf...
Clinical trial

An exploratory phase IIa study to evaluate the safety and immunological effects of intravenous interferon?-1a (IFN?-1a, Rebif�) therapy in the induction of tolerance to IFN? in MS patients with neutralising antibodies (NAbs) to subcutaneous IFN?-1a (Rebif

Read time: 1 mins
Last updated:8th Dec 2010
Perform a �proof-of-concept� phase IIa clinical trial to induce tolerance to IFN? in subjects with NAbs to IFN?-1a.
Category Value
Study start date 2010-12-08

View full details